These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1100948)

  • 61. Dapsone syndrome--a case report.
    Khare AK; Bansal NK; Meena HS
    Indian J Lepr; 1987; 59(1):106-9. PubMed ID: 3611856
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Br Med J; 1971 Nov; 4(5786):514-6. PubMed ID: 4942741
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clofazimine: new products. Major antileprous drug.
    Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clofazimine for leprosy and Mycobacterium avium complex infections.
    Med Lett Drugs Ther; 1987 Aug; 29(746):77-8. PubMed ID: 3614089
    [No Abstract]   [Full Text] [Related]  

  • 65. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
    [No Abstract]   [Full Text] [Related]  

  • 67. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of treatment of lepromatous leprosy patients in the Netherlands.
    Faber WR; Leiker DL
    Dermatologica; 1979; 158(1):46-54. PubMed ID: 367843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):135-9. PubMed ID: 945234
    [No Abstract]   [Full Text] [Related]  

  • 70. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
    Chattopadhyay SP; Gupta CM; Bhate RD; Bhate RP; Sreevatsa
    Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Leprosy and its chemotherapy.
    Beeching NJ; Ellis CJ
    J Antimicrob Chemother; 1982 Aug; 10(2):81-4. PubMed ID: 6749788
    [No Abstract]   [Full Text] [Related]  

  • 72. Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
    Reeve PA; Ala J; Hall JJ
    J Trop Med Hyg; 1992 Aug; 95(4):266-70. PubMed ID: 1386634
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
    [No Abstract]   [Full Text] [Related]  

  • 74. A statistical analysis of two chemotherapy trials in lepromatous leprosy. II. Interactions among patient variables.
    Am J Trop Med Hyg; 1978 Sep; 27(5):1015-8. PubMed ID: 362951
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Workshop on "chemotherapy of leprosy" at the Central Leprosy Teaching and Research Institute, Chengalpattu (Tamil Nadu) on 21 January 1978.
    Lepr India; 1979 Jan; 51(1):115-39. PubMed ID: 449282
    [No Abstract]   [Full Text] [Related]  

  • 76. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 77. Leprosy.
    Lockwood D
    Clin Evid; 2002 Dec; (8):709-20. PubMed ID: 12603909
    [No Abstract]   [Full Text] [Related]  

  • 78. Remitting seronegative symmetrical synovitis with pitting edema in leprosy.
    Helling CA; Locursio A; Manzur ME; Sormani de Fonseca ML
    Clin Rheumatol; 2006 Feb; 25(1):95-7. PubMed ID: 16175431
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B; Girdhar BK
    Indian J Lepr; 1986; 58(1):73-8. PubMed ID: 3746000
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A study of cell mediated immunity in leprosy.
    Dubey GK; Joglekar VK; Hardas UD; Chaubey BS
    Lepr India; 1981 Apr; 53(2):197-203. PubMed ID: 7253571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.